Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 15.72 is 31% below its 3-year average of 22.83, around the middle of its 3-year range (0.00–45.91).
As of the fiscal period ended Tuesday, June 30, 2026. 38.63% below its 12-month average of 25.62.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 15.72.
QUICK RATIO (ACID-TEST)
15.72
QUICK RATIO (ACID-TEST) AVG TTM
25.62
QUICK RATIO (ACID-TEST) AVG 3Y
24.59
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-38.63%
CURRENT VS 3Y AVG
-36.07%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.32
median of 859 covered companies
CURRENT VS SECTOR MEDIAN
+373.53%
vs the sector median at left
Rapport Therapeutics, Inc. Common Stock
Market Cap
$1.46B
Quick Ratio (Acid-Test)
15.72
TTM Avg
25.62
3Y Avg
24.59
5Y Avg
N/A
Market Cap
$1.45B
Quick Ratio (Acid-Test)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.46B
Quick Ratio (Acid-Test)
28.70
TTM Avg
25.68
3Y Avg
28.23
5Y Avg
39.61
Market Cap
$1.44B
Quick Ratio (Acid-Test)
2.94
TTM Avg
3.04
3Y Avg
2.84
5Y Avg
2.90
Market Cap
$1.43B
Quick Ratio (Acid-Test)
18.31
TTM Avg
12.63
3Y Avg
8.12
5Y Avg
8.12
Market Cap
$1.43B
Quick Ratio (Acid-Test)
1.56
TTM Avg
2.29
3Y Avg
2.59
5Y Avg
3.62
Market Cap
$1.42B
Quick Ratio (Acid-Test)
5.61
TTM Avg
9.29
3Y Avg
11.65
5Y Avg
16.84
Market Cap
$1.49B
Quick Ratio (Acid-Test)
1.27
TTM Avg
1.26
3Y Avg
1.48
5Y Avg
1.54
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rapport Therapeutics, Inc. Common Stock (RAPP) | $1.46B | 15.72 | 25.62 | 24.59 | N/A |
| Braveheart Bio, Inc. (BRVE)vs › | $1.45B | N/A | N/A | N/A | N/A |
| GH Research PLC (GHRS)vs › | $1.46B | 28.70 | 25.68 | 28.23 | 39.61 |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.44B | 2.94 | 3.04 | 2.84 | 2.90 |
| Certara, Inc. (CERT)vs › | $1.44B | 2.55 | 2.09 | 2.53 | 2.95 |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.43B | 18.31 | 12.63 | 8.12 | 8.12 |
| Ultragenyx Pharmaceutical Inc. (RARE)vs › | $1.43B | 1.56 | 2.29 | 2.59 | 3.62 |
| AnaptysBio, Inc. (ANAB)vs › | $1.42B | 5.61 | 9.29 | 11.65 | 16.84 |
| Phibro Animal Health Corporation (PAHC)vs › | $1.49B | 1.27 | 1.26 | 1.48 | 1.54 |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.49B | 1.30 | 1.23 | 1.77 | 3.05 |
Quick Ratio
15.72
Excludes inventory
Current Ratio
15.72
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 15.72 |
| 2026-03-31 | 27.08 |
| 2025-12-31 | 26.17 |
| 2025-09-30 | 36.37 |
| 2025-06-30 | 22.75 |
| 2025-03-31 | 31.01 |
| 2024-12-31 | 35.34 |
| 2024-09-30 | 45.91 |
| 2024-06-30 | 42.08 |
| 2024-03-31 | 20.10 |
| 2023-12-31 | 17.14 |
| 2023-09-30 | 0.00 |
| 2023-06-30 | 0.00 |
| 2023-03-31 | 0.00 |
